Peters Stephen P
Center for Human Genomics and Department of Medicine, Section on Pulmonary and Critical Care Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
Clin Rev Allergy Immunol. 2004 Dec;27(3):197-205. doi: 10.1385/CRIAI:27:3:197.
Asthma treatment is evolving as we enter the 21st century. This review focuses on several different areas of asthma treatment now in evolution. These include: (1) the proper role of various asthma controllers--either already approved or under investigation--besides inhaled corticosteriods in asthma therapy; (2) the potential role for immune and cytokine modulation for asthma therapy; (3) the potential role for pharmacogenetics in asthma therapy; and (4) whether single-inhaler therapy with a combination of an inhaled corticosteriod and a long-acted beta-agonist could be used for both maintenance and rescue in patients with asthma.
随着我们步入21世纪,哮喘治疗也在不断发展。本综述聚焦于目前正在发展的哮喘治疗的几个不同领域。这些领域包括:(1)除吸入性皮质类固醇外,各种已获批或正在研究的哮喘控制药物在哮喘治疗中的恰当作用;(2)免疫和细胞因子调节在哮喘治疗中的潜在作用;(3)药物遗传学在哮喘治疗中的潜在作用;以及(4)吸入性皮质类固醇与长效β受体激动剂联合的单吸入器疗法是否可用于哮喘患者的维持治疗和急救治疗。